1) Choi, B., Kim, J.E., Park, S.O., Kim, E.Y., Oh, S., Choi, H., Yoon, D., Min, H.J., Kim, H.R., and Chang, E.J. (2022). Sphingosine-1-phosphate hinders the osteogenic differentiation of dental pulp stem cells in association with AKT signaling pathways. Int J Oral Sci 14, 21. 10.1038/s41368-022-00173-5.
2) Chung, C.H., Jung, W., Keum, H., Kim, T.W., and Jon, S. (2020). Nanoparticles Derived from the Natural Antioxidant Rosmarinic Acid Ameliorate Acute Inflammatory Bowel Disease. ACS Nano 14, 6887-6896. 10.1021/acsnano.0c01018.
3) Kwon, K., Cho, H., Lee, S., Cho, E.J., Yu, W., Kok, C.Y.L., Je, H.S., Kim, J.-I., Cho, H.J., and Kwon, T. (2022). Adaptive cellular response of the substantia nigra dopaminergic neurons upon age-dependent iron accumulation. Aging Cell 21, e13694. https://doi.org/10.1111/acel.13694.
4) Hwang, C., Choi, M.-H., Kim, H.-E., Jeong, S.-H., and Park, J.-U. (2022). Reactive oxygen species-generating hydrogel platform for enhanced antibacterial therapy. NPG Asia Materials 14, 72. 10.1038/s41427-022-00420-5.
5) Jang, M., Oh, S.W., Lee, Y., Kim, J.Y., Ji, E.S., and Kim, P. (2022). Targeting extracellular matrix glycation to attenuate fibroblast activation. Acta Biomaterialia 141, 255-263. https://doi.org/10.1016/j.actbio.2022.01.040.
6) Keum, H., Kim, D., Kim, J., Kim, T.W., Whang, C.-H., Jung, W., and Jon, S. (2021). A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis. Biomaterials 275, 120986. https://doi.org/10.1016/j.biomaterials.2021.120986.
7) Kim, T.Y., Kim, J.-Y., Kwon, H.C., Jeon, S., Lee, S.j., Jung, H., Kim, S., Jang, D.S., and Lee, C.J. (2022). Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation. Antiviral Research 208, 105428. https://doi.org/10.1016/j.antiviral.2022.105428.
8) Kang, J.-Y., Kim, H., Mun, D., Yun, N., and Joung, B. (2021). Co-delivery of curcumin and miRNA-144-3p using heart-targeted extracellular vesicles enhances the therapeutic efficacy for myocardial infarction. Journal of Controlled Release 331, 62-73. https://doi.org/10.1016/j.jconrel.2021.01.018.